93592-17-7

Upstream product

• 93592-81-5 N-(2-Benzoyl-phenyl)-2-(1,3-dioxo-1,3-dihydro-isoindol-2-yl)-N-(1-methyl-piperidin-4-yl)-acetamide 
• 93592-26-8 N-<1-(ethoxycarbonyl)-4-piperidinyl>-2-benzoylaniline 
• 96110-99-5 ethyl 2-[[[2-(1-methyl-4-piperidinyl)aminophenyl](phenyl)methylen]amino]acetate 
• 93593-07-8 2-benzoyl-N-(1-methyl-4-piperidinyl)aniline 
• 96110-83-7 2-(1-methyl-4-piperidinyl)aminobenzophenone imine 
• 541-41-3 chloroformic acid ethyl ester 
• 93592-71-3 1-(1-methyl-4-piperidinyl)-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one 

Downstream Products

• 93591-97-0 1,3-dihydro-1-(4-piperidinyl)-5-phenyl-2H-1,4-benzodiazepin-2-one 

Relevant academic research and scientific papers

Process for preparing 1-substituted-1,4-benzodiazepine derivatives

Improvement in the production of psychotropic 1-substituted-1,3-dihydro-1,4-benzodiazepin-2-ones starting from 2-(1-substituted)amino-benzophenonimines through novel intermediates of the formula: STR1 (wherein R is hydrogen, methyl or benzyl, R1/sup

1-Azacycloalkyl-1,4-benzodiazepin-2-ones with Antianxiety-Antidepressant Actions

A series of 1-azacycloalkyl-1,4-benzodiazepin-2-ones were synthesized from 1-azacycloalkyl-2-benzoylanilines 2-4 and corresponding imines 5 and 6 and then evaluated for their central nervous system activities.Pharmacological data showed that some of these

1,4-Benzodiazepine derivatives

1,4-Benzodiazepine derivatives of the formula: STR1 (in which R1 is pyrrolidinyl or piperidinyl each optionally substituted by C1-3 alkyl, phenyl-C1-3 alkyl, C1-5 alkanoyl, or C2-5 alkoxycarbonyl, R2 is hydrogen, hydroxy, or acetoxy, R3 is C1-3 alkyl, phenyl-C1-3 alkyl, or phenyl optionally substituted by one or two halogens, X is hydrogen, halogen, C1-3 alkyl, C1-3 alkoxy, nitro, trifluoromethyl, or di-C1-3 alkyl-amino, and n is 1 or 2) or pharmaceutically acceptable acid addition salts thereof, which are useful as a psychotropic agent such as anti-depressant or anxiolytic agent can be prepared from several routes.